Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)-Reference-Cited by-同舟云学术

Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again)

Published:2006-03-09 Issue:6 Volume:45 Page:649-652
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Deighton C. M.,George E.,Kiely P. D. W.,Ledingham J.,Luqmani R. A.,Scott D. G. I.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/45/6/649/5048423/kel053.pdf

Reference29 articles.

1. British Society for Rheumatology. Guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis. London: British Society for Rheumatology,2001 (www.rheumatology.org.uk).

2. National Institute of Clinical Excellence. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. March2002. http://www.nice.org.uk/pdf/RA-PDF.pdf.

3. Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology2005;44:157–63.

4. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis2002 update. Arthritis Rheum 2002;46:328–46.

5. Hjardem E, Hetland ML, Østergaard M, Krogh NS, Kvein TK. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent. Ann Rheum Dis2005;64:1220–3.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry;BioMed Research International;2014

2. Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients;Reumatismo;2011-09-12

3. The use of low-dose etanercept as an alternative therapy for treatment of ankylosing spondylitis: a case series;Rheumatology International;2011-05-08

4. Tumor necrosis factor blocking therapies;Rheumatology;2011

5. Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls;Immunotherapy;2010-11